Cargando…

Heme oxygenase-1 gene promoter polymorphisms are associated with coronary heart disease and restenosis after percutaneous coronary intervention: a meta-analysis

Numerous published studies have suggested that there is association between heme oxygenase-1 (HO-1) gene polymorphisms and coronary heart disease (CHD) or restenosis (RS) after percutaneous coronary intervention (PCI). This study aimed to clarify this association using a meta-analysis method. We use...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ming-Ming, Zheng, Ying-Ying, Gao, Ying, Zhang, Jing-Zhan, Liu, Fen, Yang, Yi-Ning, Li, Xiao-Mei, Ma, Yi-Tong, Xie, Xiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347780/ https://www.ncbi.nlm.nih.gov/pubmed/27825138 http://dx.doi.org/10.18632/oncotarget.13118

Ejemplares similares

Increased serum resistin level is associated with coronary heart disease
por: Zhang, Jing-Zhan, et al.
Publicado: (2017)

Association between C1019T polymorphism of the connexin37 gene and coronary heart disease in patients with in-stent restenosis
por: GUO, SU-XIA, et al.
Publicado: (2013)

In stent restenosis after percutaneous coronary intervention
por: Eyüboğlu, Mehmet
Publicado: (2016)

The number of stents was an independent risk of stent restenosis in patients undergoing percutaneous coronary intervention
por: Tang, Long, et al.
Publicado: (2019)

Systematic Review of Chinese Herbal Medicines for Preventing in-Stent Coronary Restenosis after Percutaneous Coronary Intervention
por: Zheng, Guo-Hua, et al.
Publicado: (2012)

Drug-Eluting Balloons versus Second-Generation Drug-Eluting Stents for Treating In-Stent Restenosis in Coronary Heart Disease after PCI: A Meta-Analysis
por: Xiu, Wen-Juan, et al.
Publicado: (2018)

Serum Bilirubin and Ferritin Levels Link Heme Oxygenase-1 Gene Promoter Polymorphism and Susceptibility to Coronary Artery Disease in Diabetic Patients
por: Chen, Ying-Hwa, et al.
Publicado: (2008)

Coronary restenosis
Publicado: (1993)

Model for End-Stage Liver Disease Score Predicts the Mortality of Patients with Coronary Heart Disease Who Underwent Percutaneous Coronary Intervention
por: Chen, You, et al.
Publicado: (2021)

Association of Egr3 genetic polymorphisms and coronary artery disease in the Uygur and Han of China
por: Li, Xia, et al.
Publicado: (2014)

Relationship between a Novel Polymorphism of the C5L2 Gene and Coronary Artery Disease
por: Zheng, Ying-Ying, et al.
Publicado: (2011)

Serum Homocysteine Level Predictive Capability for Severity of Restenosis Post Percutaneous Coronary Intervention
por: Guo, Jiqiang, et al.
Publicado: (2022)

The Fibrinogen-to-Albumin Ratio Is Associated With Outcomes in Patients With Coronary Artery Disease Who Underwent Percutaneous Coronary Intervention
por: Zhang, Da-Peng, et al.
Publicado: (2020)

Impact of anemia on in-stent restenosis after percutaneous coronary intervention
por: Hu, Huilin, et al.
Publicado: (2021)

Coronary collaterals and risk for restenosis after percutaneous coronary interventions: a meta-analysis
por: Meier, Pascal, et al.
Publicado: (2012)

Plasma Heme Oxygenase-1 Levels in Patients with Coronary and Peripheral Artery Diseases
por: Kishimoto, Yoshimi, et al.
Publicado: (2018)

Heme Oxygenase-1, Oxidation, Inflammation, and Atherosclerosis
por: Araujo, Jesus A., et al.
Publicado: (2012)

The effect of Huoxue Huayu decoction on restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis
por: Hou, Yi, et al.
Publicado: (2022)

Predictive value of LncRNA on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis
por: Liu, Shengxiang, et al.
Publicado: (2021)

Genetic Polymorphism of Angiotensin Converting Enzyme and Risk of Coronary Restenosis after Percutaneous Transluminal Coronary Angioplasties: Evidence from 33 Cohort Studies
por: Wang, Shen, et al.
Publicado: (2013)

The effectiveness of Salvianolate injection for in-stent restenosis after percutaneous coronary intervention: A protocol for systematic review and meta-analysis
por: Zhang, Miao, et al.
Publicado: (2022)

Association of Circulating Heme Oxygenase-1, Lipid Profile and Coronary Disease Phenotype in Patients with Chronic Coronary Syndrome
por: Caselli, Chiara, et al.
Publicado: (2021)

An analysis of factors related to the development of in-stent restenosis after percutaneous coronary intervention
por: Zhang, Gai, et al.
Publicado: (2020)

Red blood cell distribution width as long-term prognostic markers in patients with coronary artery disease undergoing percutaneous coronary intervention
por: Wu, Ting-Ting, et al.
Publicado: (2019)

Predictive Value of COPD History on In-Stent Restenosis in Coronary Arteries Following Percutaneous Coronary Intervention
por: Hou, Ling, et al.
Publicado: (2023)

Factors Affecting In-stent Restenosis in Patients Undergoing Percutaneous Coronary Angioplasty
por: Sajadian, Mostafa, et al.
Publicado: (2018)

Coated stents to prevent restenosis in coronary heart disease
por: Gorenoi, Vitali, et al.
Publicado: (2005)

Curcumin inhibits HCV replication by induction of heme oxygenase-1 and suppression of AKT
por: CHEN, MING-HO, et al.
Publicado: (2012)

AGTR1rs5186 Polymorphism Is Associated with the Risk of Restenosis after Percutaneous Coronary Intervention: A Meta-Analysis
por: Lv, Feng, et al.
Publicado: (2022)

New predictors of in-stent restenosis in patients with diabetes mellitus undergoing percutaneous coronary intervention with drug-eluting stent
por: Wang, Jian-Long, et al.
Publicado: (2018)

Association of C5L2 genetic polymorphisms with coronary artery disease in a Han population in Xinjiang, China
por: Zheng, Ying-Ying, et al.
Publicado: (2016)

Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention
por: Wu, Ting-Ting, et al.
Publicado: (2019)

Resting Heart Rate and Long-Term Outcomes in Patients with Percutaneous Coronary Intervention: Results from a 10-Year Follow-Up of the CORFCHD-PCI Study
por: Zheng, Ying-Ying, et al.
Publicado: (2019)

Enzymological and structural characterization of Arabidopsis thaliana heme oxygenase‐1
por: Wang, Jia, et al.
Publicado: (2022)

A novel polymorphism (901G > a) of C5L2 gene is associated with coronary artery disease in Chinese Han and Uyghur population
por: Zheng, Ying-Ying, et al.
Publicado: (2013)

ALB-dNLR Score Predicts Mortality in Coronary Artery Disease Patients After Percutaneous Coronary Intervention
por: Xiu, Wen-Juan, et al.
Publicado: (2022)

Arterial stiffness in patients with coronary artery disease: relation with in-stent restenosis following percutaneous coronary intervention
por: Prskalo, Zrinko, et al.
Publicado: (2016)

Association of C5aR1genetic polymorphisms with coronary artery disease in a Han population in Xinjiang, China
por: Zheng, Ying-Ying, et al.
Publicado: (2015)

Predictive value of inflammatory factors on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis
por: Chu, Xin, et al.
Publicado: (2021)

Microsatellite Polymorphism in the Heme Oxygenase-1 Gene Promoter and the Risk of Atrial Fibrillation in Taiwanese
por: Hsu, Lung-An, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ps8c34eij8a5hjdkbcief2tcnr